source
- Will AI like Claude ever earn a Nobel Prize in medicine?Jeffrey S. Flier, a distinguished professor at Harvard and former dean of Harvard Medical School, writes an opinion piece prompted by the recent Nobel announcement. He asks whether an artificial-in…
- FDA Requests Public Feedback on Designing Early-Phase Trials for Psychedelic Drug IbogaineThe U.S. Food and Drug Administration announced it is seeking comments from the public on how to structure early-phase clinical studies of ibogaine, a plant-derived psychoactive compound. The agen…